Science and Therapeutic Area
We have two monoclonal antibody production bases in China, located in Wujiang, Suzhou and Lingang, Shanghai.
We always prioritize the quality management of products by establishing comprehensive standards, processes and specifications to guarantee the production of high-quality products.
Obtained GMP Certificate
4,500L commercial capability
Construction completed in 2016
Ongoing production of commercial and investigational products
Construction in compliance with CGMP standards
Phase I project fermentation capability reaches 30,000L
Obtained GMP Certificate in May, 2022